Skip to main content

ADVISORY/ HTS Biosystems & Applied Biosystems to Present Research on Next-Generation Protein Affinity Array Technology at IBC's Annual International Conference on Antibody Engineering. 


 
Who/What:            New research on HTS Biosystems' and Applied 
                     Biosystems' proprietary biomolecular kinetic 
                     analysis technology will be presented at IBC Life 
                     Sciences' 13th Annual International Conference on 
                     Antibody Engineering (December 1-4, 2002). This 
                     next-generation microarray-based SPR (surface 
                     plasmon resonsance) system is designed to help 
                     researchers profile and characterize biomolecular 
                     interactions in a parallel format, while 
                     decreasing costs associated with this productive 
                     type of quantitative analysis. 
 
                     Highlights: 
 
                     -    Early access users of the technology, the 
                          University of Utah and Dyax Corp., will 
                          present their preliminary utility experience 
                          with the system. 
 
                     -    Demonstrations of the technology's user 
                          interface will be offered at the Applied 
                          Biosystems booth at the conference. 
 
Why:                 -    The Antibody Engineering Meeting will 
                          enable HTS Biosystems and Applied Biosystems 
                          to showcase their progress in the 
                          development of advanced, label-free SPR 
                          array technology designed to accelerate drug 
                          discovery R&D with higher throughput, 
                          content-rich biomolecular binding 
                          characterization screening. 
 
 
 
Where:               Paradise Point Resort 
                     1404 Vacation Road 
                     San Diego, CA 92109 
 
When:                The oral research presentations include: 
 
                     -    Sunday, December 1, 1:40 p.m. (PST): 
                          Affinity Biosensing to the nth Degree 
                          (Dr. David Myszka, Center for Biomolecular 
                          Interaction Analysis, University of Utah) 
 
                     -    Monday, December 2, 4:30 p.m. (PST): 
                          A Microarray-Based Surface Plasmon Resonance 
                          Method For the Rapid Determination of Phage 
                          Display Derived Human Antibody Dissociation 
                          Constants 
                          (Dr. Dan Sexton, Investigator, Dyax 
                          Corporation) 
 
                     Data from the abstracts are embargoed to the 
                     press until after each presentation. For more 
                     information, or to obtain a copy of the abstract, 
                     please visit: 
                     http://www.lifesciencesinfo.com/antibodyeng 
 
 
About HTS            HTS Biosystems, Inc. is a privately held 
Biosystems:          biotechnology company specializing in 
                     high-throughput bioanalytical systems for the 
                     rapidly growing field of proteomics. HTS 
                     Biosystems offers a unique portfolio of 
                     innovative technologies that support all phases 
                     of proteomics, from discovery to development of 
                     therapeutic and diagnostic products. The 
                     company's technology platform - the 
                     Proteomatrix(TM) Solution - streamlines the 
                     discovery process and captures fixed costs for 
                     more effective use of protein data in target 
                     screening, validation, and discovery efforts. 
                     Collaborations with key industry partners, such 
                     as Applied Biosystems, Dyax Corporation, 
                     Mitsubishi Chemical Corporation, and Molsoft LLC 
                     have driven the development of the company's 
                     technologies and related systems, including the 
                     joint HTS Biosystems-Applied Biosystems 
                     next-generation SPR array technology platform, 
                     the CHEMI FLEX(TM) System, and the PHASE FLEX(TM) 
                     System for target discovery, screening and 
                     validation. HTS Biosystems' operations are 
                     located in Hopkinton, MA. For more information, 
                     visit www.htsbiosystems.com 
 
About Applied        Applied Biosystems, a business unit of Applera 
Biosystems:          Corporation, develops and markets 
                     instrument-based systems, reagents, software, and 
                     contract related services to the life science 
                     industry and research community. These 
                     technologies enable biological discoveries in 
                     life science research, pharmaceutical research 
                     and development, diagnostics, and agriculture. 
                     Its broad portfolio of technologies, which 
                     includes DNA sequencing, PCR, organic synthesis, 
                     chemiluminescence, mass spectrometry, and 
                     information management systems, enable genomics, 
                     proteomics, high throughput screening, and other 
                     molecular analyses. For more information, visit: 
                     http://www.appliedbiosystems.com

Comments

Post a Comment

Popular posts from this blog

Viacom Puts HTS Network on the Block

  Viacom Inc. said yesterday that it will sell Home Team Sports, the valuable Washington regional sports cable television network, as part of the $91 billion merger of Viacom and CBS. Viacom Inc. said it will combine CBS Cable and MTV Networks as part of the deal but has no desire to own several parts of CBS Cable, including HTS; the Midwest Sports Channel, which serves Minneapolis and Milwaukee; or the advertising services firm Group W Sports Marketing. Viacom started to look for an HTS buyer even before the merger was finalized, MTV spokeswoman Carole Robinson said, adding that there are "several interested buyers," which she declined to name. CBS Cable owns 66 percent of Bethesda-based HTS, with the other 34 percent held by Fox Sports Net, which is assembling a group of regional cable sports networks throughout the United States and would be one logical purchaser. Robinson, CBS Cable spokeswoman Cheryl Daly and Jody Shapiro, a senior vice president of CBS Cabl...
Post a Comment
Read more

Applied Biosystems and HTS Biosystems Enter Alliance to Develop Key Technology for Functional Proteomics.

Applied Biosystems (NYSE:ABI), an Applera Corporation business, and HTS Biosystems Inc., a privately-held company, today announced they have entered into a licensing and supply agreement to develop and commercialize a functional proteomics system based on HTS Biosystems' high throughput affinity screening technology. Applied Biosystems holds a minority equity position in HTS Biosystems; additional financial terms were not disclosed. Under the new collaboration, the parties plan to further develop and commercialize HTS Biosystems' FLEX CHIP(TM) System -- a next generation surface plasmon resonance (SPR) technology that permits high throughput analysis of protein interactions in a more cost-effective and streamlined manner than existing technologies. The affinity, or tightness, of protein binding is an important characteristic affecting protein function. The FLEX CHIP(TM) System is a highly flexible, label-free detection platform for parallel kinetic analysis of binding...
Post a Comment
Read more

American Superconductor Announces Termination of Research Program with ABB and EDF on Development of HTS Transformer Wire.

Companies to Explore Alternate HTS Wire Methodologiesand Architectures American Superconductor Corporation (Nasdaq: AMSC) announced today the termination of funding for a research program it has been conducting to develop high temperature superconductor (HTS) wires for use in transformers. The research program was started April 1, 1997 and has been funded equally by ABB, Electricite de France (EDF) and American Superconductor. American Superconductor, EDF (one of the world's largest electric utilities and a major shareholder in American Superconductor), and ABB intend to continue joint evaluation of American Superconductor's HTS technologies for use in transformers on a no-funds-exchanged basis. "Based on the results of our work with EDF and ABB, we have made a mutual strategic decision to end the current development program on HTS transformer wire," commented Greg Yurek, American Superconductor's chief executive officer. "Our efforts will now f...
Post a Comment
Read more